CAPTOPRIL ACUTELY LOWERS ALBUMINURIA IN NORMOTENSIVE PATIENTS WITH DIABETIC NEPHROPATHY

Angiotensin-converting enzyme (ACE) inhibitors decrease albuminuria in patients with diabetic nephropathy. To study the change in albuminuria in relation to changes in systemic and renal hemodynamics, nine normotensive patients with type 1 (insulin-dependent) diabetes mellitus and persistent proteinuria were given a single oral dose of 25 mg of the ACE inhibitor captopril. Blood pressure, glomerular filtration rate (GFR), effective renal plasma flow (ERPF), and albumin excretion rate (AER) were measured in two periods of 40 minutes before and in four periods of 40 minutes after administration of captopril. A constant water diuresis was maintained. Blood pressure did not decrease significantly (130/79 ± 4/3 v 124/74 ± 4/3 mm Hg; mean ± SEM), median AER decreased from 403 (interquartile range [IOR], 812) μg/min to 333 (707) μg/min (P < 0.01). GFR did not change (123 ± 13 v 117 ± 14 mL/min), but ERPF increased significantly from 609 ± 56 to 714 ± 55 mL/min (P < 0.01). Consequently, the filtration fraction (FF; quotient of GFR and ERPF) decreased from 0.20 ± 0.014 to 0.17 ± 0.014 (P < 0.01). A strong correlation was found between the decrease of AER and the decrease of FF (rs = 0.75; P < 0.02). No correlation was found between the decrease in AER and changes in GFR or blood pressure. In the normotensive patient with diabetic nephropathy, captopril causes an acute reduction of AER, which is probably mediated by a lowering of the intraglomerular pressure. © 1992, National Kidney Foundation, Inc.. All rights reserved.